Clinical trial
Recurrence of Thromboembolic Venous Disease of Atypical Location
NCT06815874 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recurrence of Thromboembolic Venous Disease of Atypical Location
- Lead sponsor
- University Hospital, Brest
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 1, 2024
- Completion date
- February 28, 2025
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.